These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 24091937)

  • 1. RYR1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia.
    Shaaban S; Ramos-Platt L; Gilles FH; Chan WM; Andrews C; De Girolami U; Demer J; Engle EC
    JAMA Ophthalmol; 2013 Dec; 131(12):1532-40. PubMed ID: 24091937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Homozygous Missense Mutation in
    Dilaver N; Mazaheri N; Maroofian R; Zeighami J; Seifi T; Zamani M; Sedaghat A; Shariati GR; Galehdari H
    Mol Syndromol; 2017 Dec; 9(1):25-29. PubMed ID: 29456480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital ptosis, scoliosis, and malignant hyperthermia susceptibility in siblings with recessive RYR1 mutations.
    AlBakri A; Karaoui M; Alkuraya FS; Khan AO
    J AAPOS; 2015 Dec; 19(6):577-9. PubMed ID: 26691049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
    Jungbluth H; Zhou H; Hartley L; Halliger-Keller B; Messina S; Longman C; Brockington M; Robb SA; Straub V; Voit T; Swash M; Ferreiro A; Bydder G; Sewry CA; Müller C; Muntoni F
    Neurology; 2005 Dec; 65(12):1930-5. PubMed ID: 16380615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    Løseth S; Voermans NC; Torbergsen T; Lillis S; Jonsrud C; Lindal S; Kamsteeg EJ; Lammens M; Broman M; Dekomien G; Maddison P; Muntoni F; Sewry C; Radunovic A; de Visser M; Straub V; van Engelen B; Jungbluth H
    J Neurol; 2013 Jun; 260(6):1504-10. PubMed ID: 23329375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility.
    Taylor A; Lachlan K; Manners RM; Lotery AJ
    J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
    Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
    Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and a
    Patel RM; Liu D; Gonzaga-Jauregui C; Jhangiani S; Lu JT; Sutton VR; Fernbach SD; Azamian M; White L; Edmond JC; Paysse EA; Belmont JW; Muzny D; Lupski JR; Gibbs RA; Lewis RA; Lee BH; Lalani SR; Campeau PM
    Cold Spring Harb Mol Case Stud; 2017 Mar; 3(2):a000984. PubMed ID: 28299356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
    Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
    Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots.
    Gillies RL; Bjorksten AR; Davis M; Du Sart D
    Anaesth Intensive Care; 2008 May; 36(3):391-403. PubMed ID: 18564801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
    Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
    Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous/compound heterozygote RYR1 gene variants: Expanding the clinical spectrum.
    Alkhunaizi E; Shuster S; Shannon P; Siu VM; Darilek S; Mohila CA; Boissel S; Ellezam B; Fallet-Bianco C; Laberge AM; Zandberg J; Injeyan M; Hazrati LN; Hamdan F; Chitayat D
    Am J Med Genet A; 2019 Mar; 179(3):386-396. PubMed ID: 30652412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
    Brandt A; Schleithoff L; Jurkat-Rott K; Klingler W; Baur C; Lehmann-Horn F
    Hum Mol Genet; 1999 Oct; 8(11):2055-62. PubMed ID: 10484775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Samaritan myopathy, an ultimately benign congenital myopathy, is caused by a RYR1 mutation.
    Böhm J; Leshinsky-Silver E; Vassilopoulos S; Le Gras S; Lerman-Sagie T; Ginzberg M; Jost B; Lev D; Laporte J
    Acta Neuropathol; 2012 Oct; 124(4):575-81. PubMed ID: 22752422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel RYR1 variant in an infant with a unique fetal presentation of central core disease.
    Baker EK; Al Gharaibeh FN; Bove K; Calvo-Garcia MA; Shillington A; VandenHeuvel K; Cortezzo DE
    Am J Med Genet A; 2023 Jun; 191(6):1646-1651. PubMed ID: 36965156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy.
    Kraeva N; Heytens L; Jungbluth H; Treves S; Voermans N; Kamsteeg E; Ceuterick-de Groote C; Baets J; Riazi S
    Neuromuscul Disord; 2015 Jul; 25(7):567-76. PubMed ID: 25958340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.